Dev IT secures Rs 4-cr orders from Alivus Lifesciences
Shares of Alivus Lifesciences rose 0.50% to Rs 1,038.30 on the BSE.
According to an exchange filing, the engagement includes a major order worth Rs 3.60 crore for Microsoft Select Plus perpetual licenses. While the licenses will be billed directly by the Licensing Solution Partner, DEVIT played a key advisory role in aligning Alivus Lifesciences IT infrastructure with the appropriate Microsoft licensing model. This highlights DEVITs capability in managing complex enterprise IT requirements and supporting clients in their digital transformation initiatives.
In addition, DEVIT secured a direct order worth Rs 80 lakh from Alivus Lifesciences for a suite of enterprise software solutions. This includes products from Microsoft, Zoho, Adobe, and TeamViewer, underscoring the companys ability to deliver integrated, multi-product IT solutions tailored to specific business needs.
Dev Information Technology (DEV IT) is a technology solution provider helping companies in their digital transformation from advisory to execution, backed by expert applications and infrastructure management.
Alivus Life Sciences Limited (Formerly Glenmark Life Sciences is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management and diabetes.
Shares of Dev Information Technology shed 0.33% to Rs 121.40 on the BSE.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
15 minutes ago
- Time of India
Stem cell transplant: Insurance company told to reimburse Rs 4 lakh to liver cirrhosis patient
Surat: The consumer commission in Valsad has ordered an insurance company to pay a Rs four lakh claim for stem cell therapy administered to a liver cirrhosis patient, stating that it was a life-saving treatment. The company rejected the claim citing the policy clause, which did not cover stem cell therapy except in certain conditions. However, the Valsad Consumer Disputes Redressal Commission (CDRC) ruled that the insurer misinterpreted the clause to avoid payment. According to details, the Valsad resident was employed as a mutual fund advisor at a private asset management company. He purchased a group health insurance policy covering him and his family for a sum of Rs four lakh for a year starting September 7, 2022. The policyholder was admitted to a private hospital in Ahmedabad for stem cell treatment on May 19, 2023, and underwent a stem cell transplant for liver cirrhosis. On August 18, 2023, the company rejected the claim under clause 28, which states that stem cell therapy surgery is allowed only in haemopoietic stem cells for bone marrow transplant in haematological conditions. The policyholder approached the consumer commission on November 20, 2023. During the hearing, the company's advocate argued that the exclusion clause clearly stated that such treatment claims were ineligible under the policy terms, and the application should be rejected. Conversely, the complainant's advocate contended that the insurer misinterpreted the clause in rejecting the claim. The complainant received treatment as an indoor patient as directed by the doctor, and the letter regarding the treatment was submitted to the insurance company on September 13, 2023. The letter stated: 'Diabetes and liver cirrhosis were treated with stem cell therapy for his serious health condition, and diabetic condition occurred after corona. .. Reports indicate liver cirrhosis." However, the company did not accept the letter. After considering the arguments and documents, the commission observed: "The specific exclusions (28) mention – treatment for alopecia, baldness, wigs or toupees and all related treatments." However, the transplant was done to save his life, the commission noted. The forum also noted that the insurance firm failed to provide any expert opinion on the complainant's treatment. "Reviewing the documents, it appears that the firm wrongfully rejected the claim to avoid payment." Consequently, the commission ordered the firm to pay Rs 4 lakhs with 8% interest from January 2023 and Rs 3,000 for harassment.
India.com
17 minutes ago
- India.com
Days after getting married to Lauren Sanchez, Jeff Bezos gets richer by Rs 63000000000 due to…
Jeff Bezos, the founder of Amazon, has sold a major chunk of his Amazon shares within days after his wedding to Lauren Sanchez. According to a regulatory filing in the US and a report by Bloomberg, Bezos sold more than 3.3 million Amazon shares and earned around $736.7 million from the deal. This will value around Rs 6,300 crore in Indian currency. Why Jeff Bezos Sold Amazon Shares? This stock sale was actually a pre-planned agreement known as a 10b5-1 trading plan. It was already adopted by Bezos in March 2025. These trading plans allow top executives and insiders to sell company shares at scheduled times to avoid any concerns related to the insider trading. As per this plan, Bezos wants to sell up to 25 million Amazon shares by the end of May 2026. What Is Jeff Bezos's Net Worth Bezos, who is now the third-richest person in the world. According to Bloomberg Billionaires Index, he has sold share sales in the past. In 2023 also he sold around 75 million shares of $13.6 billion as per the same method. He had used this method to support other ventures like space exploration company, Blue Origin. His current net worth is around $241 billion. The timing of this latest stock sale was discussed more in the news because it happened after Bezos' wedding to Sanchez in Venice, Italy. The wedding ceremony, held for three days. Many celebrities from the world were invited for the same. According to media reports, the overall cost of the wedding events was around $50 million. Although the share sale happened after the wedding, it has no connection with it and was executed as part of his scheduled trading plan.
Time of India
30 minutes ago
- Time of India
Wayanad township to be ready by Dec: Rajan
Kozhikode: Revenue minister K Rajan said the homes for Mundakkai–Chooralmala disaster survivors at Elstone Estate township will be completed by Dec 2025. The township will house over 1,662 people in 410 homes. Of these, 140 people have each received a seven-cent plot. Rajan said the govt spent Rs 108 crore on survivor rehabilitation. He also instructed the use of more machinery to clear landslide debris from Punnapuzha. The minister said Rs 3.6 crore was allocated for Kudumbashree's micro plan and Rs 43.7 crore was spent on land acquisition at Elstone Estate. A total of Rs 13.3 crore was given as compensation to the families of 220 deceased people and Rs 15.6 crore was provided to 104 people as financial support of Rs 15 lakh each instead of housing. For livelihood support, Rs 10.1 crore was given to 1,133 people. Another Rs 20 crore was approved for running the township's special office. Emergency aid of Rs 1.3 crore and rental support of Rs 4.3 crore were also provided. The minister said foundation work of 51 homes is complete. Dynamic cone penetration tests were done for 54 homes and plain cement concrete work was finished in 41. Foundation work is in progress for 19 more homes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo Site preparation for the second phase of construction is progressing rapidly. Rajan said the model home will be completed by the end of July. At present, 110 workers are working on site and more labourers will be brought in soon to speed up the work, he added. Responding to the concerns raised by people in Padavettikunnu who are not on the township beneficiary list, the minister said their requests would be examined. He assured that the government would not abandon disaster-affected families. He said that a separate bank account was opened to handle all financial transactions related to construction of the township. A monitoring committee including the chief minister, the opposition leader and sponsor representatives is overseeing the full process to keep it transparent.
